» Articles » PMID: 16946180

Familial Aggregation of Illness Chronicity in Recurrent, Early-onset Major Depression Pedigrees

Abstract

Objective: The authors used a large sample collected for genetic studies to determine whether a chronic course of illness defines a familial clinical subtype in major depressive disorder.

Method: A measure of lifetime chronicity of depressive symptoms (substantial mood symptoms most or all of the time) was tested for familial aggregation in 638 pedigrees from the Genetics of Recurrent Early-Onset Depression (GenRED) project.

Results: In subjects with chronic depression, the mean age at illness onset was lower and rates of attempted suicide, panic disorder, and substance abuse were higher than among those with nonchronic depression. Chronicity was assessed in 37.8% of affected first-degree relatives of probands with chronic depression and in 20.2% of relatives of probands with nonchronic depression. Analysis using the generalized estimating equation model yielded an odds ratio of 2.52 (SE=0.39, z=6.02, p<0.0001) for the likelihood of chronicity in a proband predicting chronicity in an affected relative. With stratification by proband age at illness onset, the odds ratio for chronicity in relatives by proband chronicity status was 6.17 (SE=2.09, z=5.35, p<0.0001) in families of probands whose illness onset was before age 13 and 1.92 (SE=0.34, z=3.72, p<0.0001) in families of probands whose illness started at age 13 or later.

Conclusions: These findings suggest that chronicity of depressive symptoms is familial, especially in preadolescent-onset illness. Chronicity is also associated with other indicators of illness severity in recurrent, early-onset major depression. Further study using chronicity as a subtype in the genetic analysis of depressive illness is warranted. Refinement of the definition of chronicity in depressive illness may increase the power of such studies.

Citing Articles

Gender differences in major depressive disorder at different ages: a REST-meta-MDD project-based study.

Tian X, Hu N, Lu L, Tan L, Li P BMC Psychiatry. 2024; 24(1):575.

PMID: 39180019 PMC: 11342488. DOI: 10.1186/s12888-024-06021-6.


Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study.

Bliddal M, Wesselhoeft R, Strandberg-Larsen K, Ernst M, Weissman M, Gingrich J Child Adolesc Psychiatry Ment Health. 2023; 17(1):73.

PMID: 37328889 PMC: 10276495. DOI: 10.1186/s13034-023-00624-9.


The sociodemographic characteristics and clinical features of the late-life depression patients: results from the Beijing Anding Hospital mental health big data platform.

Wang X, Rao W, Chen X, Zhang X, Wang Z, Ma X BMC Psychiatry. 2022; 22(1):677.

PMID: 36324116 PMC: 9628045. DOI: 10.1186/s12888-022-04339-7.


Hycanthone Inhibits Inflammasome Activation and Neuroinflammation-Induced Depression-Like Behaviors in Mice.

Boo K, Gonzales E, Remonde C, Seong J, Jeon S, Park Y Biomol Ther (Seoul). 2022; 31(2):161-167.

PMID: 36203404 PMC: 9970841. DOI: 10.4062/biomolther.2022.073.


Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.

Navarro D, Gasparyan A, Navarrete F, Torregrosa A, Rubio G, Marin-Mayor M Int J Mol Sci. 2022; 23(9).

PMID: 35563156 PMC: 9104141. DOI: 10.3390/ijms23094764.